WHO Analgesic Ladder  ·  Multimodal  ·  Opioid-Sparing

Acute Pain Management Protocol – Evidence-Based Analgesia for All Pain Types

Inadequate pain management reduces recovery, increases suffering, and prolongs hospitalization. Our comprehensive Pain Management Protocol guides clinicians through the WHO analgesic ladder and modern multimodal pain strategies. Get personalized recommendations for somatic, visceral, and neuropathic pain. Includes opioid dosing, adjunctive medications (gabapentin, duloxetine, NSAIDs), and non-pharmacologic interventions. Opioid-sparing approach to minimize addiction risk while maximizing comfort.

Get Pain Protocol Now
WHO-endorsed ladder Opioid-sparing approach Multimodal strategies
Pain Management Strategy

Comprehensive Acute, Chronic & Cancer Pain Management

Match pain type to evidence-based treatment protocols. WHO ladder + multimodal adjuncts = superior analgesia with fewer side effects.

📋

Pain Classification

Classify pain as somatic, visceral, or neuropathic. Each type responds to different drug classes and requires specific management strategies.

🪜

WHO Analgesic Ladder

Step 1 (NSAIDs/acetaminophen), Step 2 (weak opioids), Step 3 (strong opioids). Escalate based on pain intensity and treatment response.

💊

Opioid Dosing

Morphine equivalents, dose conversion, rotation, and escalation. Account for tolerance, renal dysfunction, and comorbidities.

⚡

Adjunctive Medications

Gabapentin, pregabalin, duloxetine, SNRIs for neuropathic pain. NSAIDs, acetaminophen, and muscle relaxants for synergistic effect.

🧘

Non-Pharmacologic Options

Physical therapy, meditation, heat/cold, acupuncture, psychological interventions. Reduce opioid requirements and improve outcomes.

📊

Side Effect Management

Constipation, nausea, drowsiness, respiratory depression. Prevention and treatment protocols for common opioid adverse effects.

Clinical Implementation

WHO Ladder & Multimodal Pain Control

WHO Three-Step Analgesic Ladder

The WHO ladder is the gold standard for pain management. Escalate based on pain intensity and treatment response. Add adjuncts at any step for multimodal effect.

Step 1: Mild Pain (1-3/10)

Acetaminophen 650-1000 mg q6h (max 3-4 g/day). NSAIDs: ibuprofen 400-600 mg q6-8h, naproxen 500 mg q12h, meloxicam 7.5-15 mg daily. Add adjuncts: heat/cold, physical therapy, topical agents (capsaicin, lidocaine patch).

Step 2: Moderate Pain (4-6/10)

Weak Opioids: codeine 15-60 mg q4-6h, tramadol 50-100 mg q4-6h (max 400 mg/day), hydrocodone 5-10 mg q4-6h. Add NSAID + acetaminophen for synergy. Include gabapentin 300-900 mg daily (neuropathic) or duloxetine 30-60 mg daily (musculoskeletal).

Step 3: Severe Pain (7-10/10)

Strong Opioids: morphine ER 15-30 mg q12h + IR 5-15 mg q4h PRN, oxycodone ER 10-20 mg q12h + IR 5-10 mg q4h PRN. Fentanyl patch 25-100 mcg q72h for chronic stable pain. Mandatory: bowel regimen, antiemetics, breakthrough pain protocol (10-20% of daily dose q2-4h PRN).

Pain Type Classification

Pain Type Characteristics First-Line
Somatic Sharp, localized, aching (bone, joint, muscle) NSAIDs + acetaminophen, topical agents, PT
Visceral Dull, crampy, referred (organs) Opioids + NSAIDs, antispasmodics
Neuropathic Burning, tingling, shooting, hyperesthesia Gabapentin, pregabalin, duloxetine
Cancer Pain Mixed types, progressive, high intensity WHO ladder, aggressive opioid titration, adjuncts

Multimodal Combinations

  • Post-Surgical: Acetaminophen 1000 mg q8h + ibuprofen 400 mg q6h + oxycodone 5-10 mg q4h PRN + gabapentin 300 mg q8h
  • Chronic Musculoskeletal: Duloxetine 60 mg daily + ibuprofen 400 mg q8h + gabapentin 900-1800 mg daily + lidocaine patches + physical therapy
  • Cancer Pain: Morphine ER 15-30 mg q12h + morphine IR 5-15 mg q2-4h PRN + gabapentin for neuropathic + prednisone 20-40 mg daily
  • Neuropathic: Pregabalin 300-600 mg daily + duloxetine 60 mg daily + topical capsaicin/lidocaine. Avoid opioids (poor efficacy).
Real-World Cases

Pain Management Implementation

Case 1: Post-Op Pain (Day 2)

Situation: 56yo male, post-abdominal surgery, pain 6/10, nausea from IV morphine 4 mg q3h.

Solution: Reduce opioid to morphine 2-3 mg q3h + acetaminophen 1000 mg q8h + ibuprofen 400 mg q6h + gabapentin 300 mg q8h + ondansetron 4 mg q6h. Expected: pain 3-4/10, reduced nausea, better mobilization.

Case 2: Diabetic Neuropathy (Chronic)

Situation: 62yo, T2DM, 10-year burning foot pain (7/10), failed topical agents.

Solution: Pregabalin 150 mg daily → 300-600 mg daily + duloxetine 30-60 mg daily + lidocaine patches 5% + optimize glucose. Expected: pain 2-3/10 in 4-6 weeks. Avoid opioids (ineffective for neuropathic pain).

Case 3: Cancer Pain Escalation

Situation: 71yo, stage IV lung + bone mets, pain 8/10 despite acetaminophen + NSAIDs.

Solution: Start morphine ER 15 mg q12h + morphine IR 5-10 mg q2-4h PRN + gabapentin 300 mg q8h + prednisone 20 mg daily + docusate + senna nightly. Expected: pain 2-3/10 within days, titrate up as needed. Involve palliative care.

Case 4: Migraine Prevention

Acute: Sumatriptan 50-100 mg + NSAID at onset. Prevention (≥4 days/month): Propranolol 40-80 mg daily OR topiramate 25-100 mg daily. Goal: reduce frequency 50%. Avoid high-dose opioids (worsen migraines). CGRP antagonist (erenumab) for refractory cases.

Common Questions

Pain Management FAQ

How do I transition from acute to chronic pain management?
Acute pain (post-op, trauma): use opioids liberally, wean as healing progresses (2-4 weeks). Chronic pain (≥3-6 months): shift to multimodal (adjuncts, behavioral interventions), minimize opioids. Document pain improvement with functional milestones, not just numeric scores. Introduce adjuncts, then gradually reduce opioid.
When should I use opioid-induced constipation prevention?
From day 1 of opioids. Stool softener (docusate 100 mg daily) + osmotic laxative (polyethylene glycol) OR stimulant (senna 1-3 tabs nightly). Monitor frequency (goal: soft stool q1-3 days). Refractory cases: methylnaltrexone (peripheral opioid antagonist) or naloxegol. NEVER use naloxone PO (causes withdrawal).
What's the maximum safe daily opioid dose?
No fixed maximum for cancer pain. For chronic non-cancer pain, CDC recommends caution ≥50 morphine equivalents/day, serious risk ≥90 mEq/day. Higher doses increase overdose risk, especially with benzodiazepines. If escalating beyond 50 mEq/day: require urine drug screen, opioid agreement, CSMP enrollment, pain specialist evaluation.
How do I prescribe breakthrough pain medication?
Give immediate-release opioid at 10-20% of total daily long-acting dose, q2-4h PRN. Example: morphine ER 60 mg/day → breakthrough dose 6-12 mg IR q2-4h PRN. If breakthrough needed >2-3 times/day, increase baseline ER instead (prevent overmedication).
Can I use opioids for neuropathic pain?
Neuropathic pain responds poorly to opioids. Gabapentin/pregabalin and duloxetine are far superior. Tramadol (weak opioid + SNRI) has some utility. Avoid high-dose opioids for pure neuropathic pain (ineffective, high side effects). Consider combination: low-dose opioid (if somatic) + gabapentin + duloxetine.
What side effects require active management?
Big 4: (1) Constipation—prevent with laxatives from day 1. (2) Nausea—ondansetron, prochlorperazine; often resolves in days. (3) Drowsiness—time for tolerance; if severe, switch opioid. (4) Respiratory depression—rare in opioid-tolerant; monitor RR ≥8. Keep naloxone available for overdose.
What's the difference between tolerance, physical dependence, and addiction?
Tolerance: Decreased effect over time; requires dose increase (normal). Physical dependence: Body adapts; withdrawal if stopped abruptly (normal, not addiction). Addiction: Compulsive use despite harm, loss of control (behavioral disorder requiring treatment). Not all opioid patients develop addiction—don't confuse tolerance/dependence with addiction.
When should I refer to pain specialists?
Refer for: (1) Refractory pain despite multimodal therapy, (2) Complex pain (multiple sites, mixed types), (3) Interventional procedures (nerve blocks, spinal infusions), (4) Opioid rotation, (5) Substance use history. Palliative care: advanced cancer, end-of-life planning, high symptom burden, goals-of-care discussions.
How do I dose medications in patients with renal/hepatic disease?
Renal failure: reduce NSAIDs (nephrotoxic), adjust opioid doses (accumulation risk), monitor acetaminophen dose (<3 g/day). Gabapentin/pregabalin require renal dosing (reduce by GFR). Liver disease: reduce opioid doses (metabolism), avoid acetaminophen >2 g/day (hepatotoxicity). NSAIDs risky in cirrhosis (GI bleeding, renal failure). Consult pharmacist for complex patients.
How do I manage pain in patients with substance use history?
Complex—requires specialized approach. Key: (1) Multimodal (non-opioid heavy), (2) If opioids needed: single prescriber/pharmacy, frequent monitoring, urine drug screens, (3) Concurrent medication-assisted treatment (methadone, buprenorphine) complicates dosing—specialist required, (4) Avoid benzodiazepines (overdose risk), (5) Behavioral interventions (PT, CBT, mindfulness) essential.
Why Multimodal Pain Management

Superior Analgesia with Lower Opioid Doses

Opioid Crisis: Opioid addiction and overdose deaths are at epidemic levels. Multimodal analgesia achieves better pain control with lower opioid doses and reduced addiction risk.

Side Effect Reduction: Combining multiple drug classes at lower doses reduces adverse effects (constipation, respiratory depression, drowsiness) compared to high-dose single agents.

Evidence-Based: The WHO analgesic ladder and multimodal approach are gold standards taught in medical schools and endorsed by major pain societies worldwide.

  • WHO 3-step ladder for pain escalation
  • Multimodal combinations for synergistic effect
  • Neuropathic pain protocols (gabapentin, duloxetine)
  • Cancer pain management strategies
  • Opioid dosing with morphine equivalents
  • Adjunctive medications to spare opioids
  • Non-pharmacologic interventions included
  • Addiction risk assessment and mitigation
Pain Management Protocol – WHO Analgesic Ladder, Opioid Dosing, Multimodal Analgesia | AimediLabs
WHO Analgesic Ladder  ·  Multimodal  ·  Opioid-Sparing

Acute Pain Management Protocol – Evidence-Based Analgesia for All Pain Types

Inadequate pain management reduces recovery, increases suffering, and prolongs hospitalization. Our comprehensive Pain Management Protocol guides clinicians through the WHO analgesic ladder and modern multimodal pain strategies. Get personalized recommendations for somatic, visceral, and neuropathic pain. Includes opioid dosing, adjunctive medications (gabapentin, duloxetine, NSAIDs), and non-pharmacologic interventions. Opioid-sparing approach to minimize addiction risk while maximizing comfort.

Get Pain Protocol Now
WHO-endorsed ladder Opioid-sparing approach Multimodal strategies
Pain Management Strategy

Comprehensive Acute, Chronic & Cancer Pain Management

Match pain type to evidence-based treatment protocols. WHO ladder + multimodal adjuncts = superior analgesia with fewer side effects.

📋

Pain Classification

Classify pain as somatic, visceral, or neuropathic. Each type responds to different drug classes and requires specific management strategies.

🪜

WHO Analgesic Ladder

Step 1 (NSAIDs/acetaminophen), Step 2 (weak opioids), Step 3 (strong opioids). Escalate based on pain intensity and treatment response.

💊

Opioid Dosing

Morphine equivalents, dose conversion, rotation, and escalation. Account for tolerance, renal dysfunction, and comorbidities.

⚡

Adjunctive Medications

Gabapentin, pregabalin, duloxetine, SNRIs for neuropathic pain. NSAIDs, acetaminophen, and muscle relaxants for synergistic effect.

🧘

Non-Pharmacologic Options

Physical therapy, meditation, heat/cold, acupuncture, psychological interventions. Reduce opioid requirements and improve outcomes.

📊

Side Effect Management

Constipation, nausea, drowsiness, respiratory depression. Prevention and treatment protocols for common opioid adverse effects.

Clinical Implementation

WHO Ladder & Multimodal Pain Control

WHO Three-Step Analgesic Ladder

The WHO ladder is the gold standard for pain management. Escalate based on pain intensity and treatment response. Add adjuncts at any step for multimodal effect.

Step 1: Mild Pain (1-3/10)

Acetaminophen 650-1000 mg q6h (max 3-4 g/day). NSAIDs: ibuprofen 400-600 mg q6-8h, naproxen 500 mg q12h, meloxicam 7.5-15 mg daily. Add adjuncts: heat/cold, physical therapy, topical agents (capsaicin, lidocaine patch).

Step 2: Moderate Pain (4-6/10)

Weak Opioids: codeine 15-60 mg q4-6h, tramadol 50-100 mg q4-6h (max 400 mg/day), hydrocodone 5-10 mg q4-6h. Add NSAID + acetaminophen for synergy. Include gabapentin 300-900 mg daily (neuropathic) or duloxetine 30-60 mg daily (musculoskeletal).

Step 3: Severe Pain (7-10/10)

Strong Opioids: morphine ER 15-30 mg q12h + IR 5-15 mg q4h PRN, oxycodone ER 10-20 mg q12h + IR 5-10 mg q4h PRN. Fentanyl patch 25-100 mcg q72h for chronic stable pain. Mandatory: bowel regimen, antiemetics, breakthrough pain protocol (10-20% of daily dose q2-4h PRN).

Pain Type Classification

Pain Type Characteristics First-Line
Somatic Sharp, localized, aching (bone, joint, muscle) NSAIDs + acetaminophen, topical agents, PT
Visceral Dull, crampy, referred (organs) Opioids + NSAIDs, antispasmodics
Neuropathic Burning, tingling, shooting, hyperesthesia Gabapentin, pregabalin, duloxetine
Cancer Pain Mixed types, progressive, high intensity WHO ladder, aggressive opioid titration, adjuncts

Multimodal Combinations

  • Post-Surgical: Acetaminophen 1000 mg q8h + ibuprofen 400 mg q6h + oxycodone 5-10 mg q4h PRN + gabapentin 300 mg q8h
  • Chronic Musculoskeletal: Duloxetine 60 mg daily + ibuprofen 400 mg q8h + gabapentin 900-1800 mg daily + lidocaine patches + physical therapy
  • Cancer Pain: Morphine ER 15-30 mg q12h + morphine IR 5-15 mg q2-4h PRN + gabapentin for neuropathic + prednisone 20-40 mg daily
  • Neuropathic: Pregabalin 300-600 mg daily + duloxetine 60 mg daily + topical capsaicin/lidocaine. Avoid opioids (poor efficacy).
Real-World Cases

Pain Management Implementation

Case 1: Post-Op Pain (Day 2)

Situation: 56yo male, post-abdominal surgery, pain 6/10, nausea from IV morphine 4 mg q3h.

Solution: Reduce opioid to morphine 2-3 mg q3h + acetaminophen 1000 mg q8h + ibuprofen 400 mg q6h + gabapentin 300 mg q8h + ondansetron 4 mg q6h. Expected: pain 3-4/10, reduced nausea, better mobilization.

Case 2: Diabetic Neuropathy (Chronic)

Situation: 62yo, T2DM, 10-year burning foot pain (7/10), failed topical agents.

Solution: Pregabalin 150 mg daily → 300-600 mg daily + duloxetine 30-60 mg daily + lidocaine patches 5% + optimize glucose. Expected: pain 2-3/10 in 4-6 weeks. Avoid opioids (ineffective for neuropathic pain).

Case 3: Cancer Pain Escalation

Situation: 71yo, stage IV lung + bone mets, pain 8/10 despite acetaminophen + NSAIDs.

Solution: Start morphine ER 15 mg q12h + morphine IR 5-10 mg q2-4h PRN + gabapentin 300 mg q8h + prednisone 20 mg daily + docusate + senna nightly. Expected: pain 2-3/10 within days, titrate up as needed. Involve palliative care.

Case 4: Migraine Prevention

Acute: Sumatriptan 50-100 mg + NSAID at onset. Prevention (≥4 days/month): Propranolol 40-80 mg daily OR topiramate 25-100 mg daily. Goal: reduce frequency 50%. Avoid high-dose opioids (worsen migraines). CGRP antagonist (erenumab) for refractory cases.

Common Questions

Pain Management FAQ

How do I transition from acute to chronic pain management?
Acute pain (post-op, trauma): use opioids liberally, wean as healing progresses (2-4 weeks). Chronic pain (≥3-6 months): shift to multimodal (adjuncts, behavioral interventions), minimize opioids. Document pain improvement with functional milestones, not just numeric scores. Introduce adjuncts, then gradually reduce opioid.
When should I use opioid-induced constipation prevention?
From day 1 of opioids. Stool softener (docusate 100 mg daily) + osmotic laxative (polyethylene glycol) OR stimulant (senna 1-3 tabs nightly). Monitor frequency (goal: soft stool q1-3 days). Refractory cases: methylnaltrexone (peripheral opioid antagonist) or naloxegol. NEVER use naloxone PO (causes withdrawal).
What's the maximum safe daily opioid dose?
No fixed maximum for cancer pain. For chronic non-cancer pain, CDC recommends caution ≥50 morphine equivalents/day, serious risk ≥90 mEq/day. Higher doses increase overdose risk, especially with benzodiazepines. If escalating beyond 50 mEq/day: require urine drug screen, opioid agreement, CSMP enrollment, pain specialist evaluation.
How do I prescribe breakthrough pain medication?
Give immediate-release opioid at 10-20% of total daily long-acting dose, q2-4h PRN. Example: morphine ER 60 mg/day → breakthrough dose 6-12 mg IR q2-4h PRN. If breakthrough needed >2-3 times/day, increase baseline ER instead (prevent overmedication).
Can I use opioids for neuropathic pain?
Neuropathic pain responds poorly to opioids. Gabapentin/pregabalin and duloxetine are far superior. Tramadol (weak opioid + SNRI) has some utility. Avoid high-dose opioids for pure neuropathic pain (ineffective, high side effects). Consider combination: low-dose opioid (if somatic) + gabapentin + duloxetine.
What side effects require active management?
Big 4: (1) Constipation—prevent with laxatives from day 1. (2) Nausea—ondansetron, prochlorperazine; often resolves in days. (3) Drowsiness—time for tolerance; if severe, switch opioid. (4) Respiratory depression—rare in opioid-tolerant; monitor RR ≥8. Keep naloxone available for overdose.
What's the difference between tolerance, physical dependence, and addiction?
Tolerance: Decreased effect over time; requires dose increase (normal). Physical dependence: Body adapts; withdrawal if stopped abruptly (normal, not addiction). Addiction: Compulsive use despite harm, loss of control (behavioral disorder requiring treatment). Not all opioid patients develop addiction—don't confuse tolerance/dependence with addiction.
When should I refer to pain specialists?
Refer for: (1) Refractory pain despite multimodal therapy, (2) Complex pain (multiple sites, mixed types), (3) Interventional procedures (nerve blocks, spinal infusions), (4) Opioid rotation, (5) Substance use history. Palliative care: advanced cancer, end-of-life planning, high symptom burden, goals-of-care discussions.
How do I dose medications in patients with renal/hepatic disease?
Renal failure: reduce NSAIDs (nephrotoxic), adjust opioid doses (accumulation risk), monitor acetaminophen dose (<3 g/day). Gabapentin/pregabalin require renal dosing (reduce by GFR). Liver disease: reduce opioid doses (metabolism), avoid acetaminophen >2 g/day (hepatotoxicity). NSAIDs risky in cirrhosis (GI bleeding, renal failure). Consult pharmacist for complex patients.
How do I manage pain in patients with substance use history?
Complex—requires specialized approach. Key: (1) Multimodal (non-opioid heavy), (2) If opioids needed: single prescriber/pharmacy, frequent monitoring, urine drug screens, (3) Concurrent medication-assisted treatment (methadone, buprenorphine) complicates dosing—specialist required, (4) Avoid benzodiazepines (overdose risk), (5) Behavioral interventions (PT, CBT, mindfulness) essential.
Why Multimodal Pain Management

Superior Analgesia with Lower Opioid Doses

Opioid Crisis: Opioid addiction and overdose deaths are at epidemic levels. Multimodal analgesia achieves better pain control with lower opioid doses and reduced addiction risk.

Side Effect Reduction: Combining multiple drug classes at lower doses reduces adverse effects (constipation, respiratory depression, drowsiness) compared to high-dose single agents.

Evidence-Based: The WHO analgesic ladder and multimodal approach are gold standards taught in medical schools and endorsed by major pain societies worldwide.

  • WHO 3-step ladder for pain escalation
  • Multimodal combinations for synergistic effect
  • Neuropathic pain protocols (gabapentin, duloxetine)
  • Cancer pain management strategies
  • Opioid dosing with morphine equivalents
  • Adjunctive medications to spare opioids
  • Non-pharmacologic interventions included
  • Addiction risk assessment and mitigation
Who Benefits

All Healthcare Professionals Managing Pain

Physicians & Surgeons Acute postoperative pain management, trauma, acute medical conditions requiring evidence-based analgesia protocols.
Nurses & Pain Specialists Implement pain management plans, patient counseling on medications and expectations, monitor effectiveness and side effects.
Palliative Care & Hospice Cancer pain and end-of-life pain management using multimodal and high-dose opioid strategies with comfort as priority.
Anesthesiologists Perioperative pain management, regional anesthesia, multimodal analgesia for enhanced recovery after surgery (ERAS).
Emergency Medicine Acute pain management in trauma, fractures, burns, and acute medical emergencies requiring rapid analgesia.
Medical Students & Residents Learn WHO ladder, multimodal pain strategies, and evidence-based approaches for board exams and clinical practice.

Get Your Pain Management Protocol

WHO ladder, multimodal adjuncts, opioid dosing — all integrated with evidence-based recommendations.

Open Pain Protocol
Disclaimer: This tool provides educational information and recommendations based on WHO guidelines. All pain management decisions must be made by qualified healthcare providers considering the individual patient's condition, medical history, and preferences. Follow institutional protocols and regulatory guidelines for opioid prescribing.